CDKN2A and Miyoshi myopathy: According to previous observations in the Italian population, a considerable fraction of MM (28%) and of FM (41%) showed CDKN2A pathogenic mutations, while they were very rare or absent in the other tested cohorts (Table 1) [27,31,56].